Effect observation of flupentixol and melitracen tablet in in the treatment of sympathetic cervical spondylosis
Tang Zhi-ha
Abstract
Tang Zhi-ha
Abstract
Objective To investigate the efficacy of flupentixol and melitracen tablet in the treatment of sympathetic cervical spondylosis.Methods 60 cases were randomly divided into treatment group and control group,30 cases of each.Both groups were given non-operative therapies,such as massage,traction and cinesiatrics,and the treatment group based on it was added flupentixol and melitracen tablet.The onset time,clinical efficacy,HAMD score and adverse reaction of 2 groups were observed. Results The onset rate at the beginning 48 hours of the treatment group was 83.3% higher than 60.0% of the control group;The total effective rate of the treatment group was 96.7% higher than 80.0% of the control group,and the differences were statistically significant(P0.01).8 weeks after treatment,the HAMD score of both groups were lower than those before treatment,and the HAMD score of the treatment group was lower than that of the control group,and all the differences were statistically significant(P0.01 and P0.05).There was no statistical significance in adverse reaction between 2 groups(P0.05).The adverse reaction of 2 groups was slight,which was relieved or dispersed after been given symptomatic therapy.There was no obvious abnormality in blood routine,hepatic and renal function,ECG and EEG.Conclusion Treating sympathetic cervical spondylosis with flupentixol and melitracen tablet has good efficacy,convenient using,high safety and good compliance,which is worth clinical popularizing and application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the efficacy of flupentixol and melitracen tablet in the treatment of sympathetic cervical spondylosis.Methods 60 cases were randomly divided into treatment group and control group,30 cases of each.Both groups were given non-operative therapies,such as massage,traction and cinesiatrics,and the treatment group based on it was added flupentixol and melitracen tablet.The onset time,clinical efficacy,HAMD score and adverse reaction of 2 groups were observed. Results The onset rate at the beginning 48 hours of the treatment group was 83.3% higher than 60.0% of the control group;The total effective rate of the treatment group was 96.7% higher than 80.0% of the control group,and the differences were statistically significant(P0.01).8 weeks after treatment,the HAMD score of both groups were lower than those before treatment,and the HAMD score of the treatment group was lower than that of the control group,and all the differences were statistically significant(P0.01 and P0.05).There was no statistical significance in adverse reaction between 2 groups(P0.05).The adverse reaction of 2 groups was slight,which was relieved or dispersed after been given symptomatic therapy.There was no obvious abnormality in blood routine,hepatic and renal function,ECG and EEG.Conclusion Treating sympathetic cervical spondylosis with flupentixol and melitracen tablet has good efficacy,convenient using,high safety and good compliance,which is worth clinical popularizing and application.
Key concepts: Medicine, Cervical spondylosis, Hamd, Anesthesia, Clinical efficacy, Adverse effect, Statistical significance, Treatment and control groups